Abstract
Stroke being the third leading cause of death and foremost cause of disability, if potential diagnostic utility of blood borne protein biomarkers in predicting acute stroke is established, it would be a substantial adjunct to computerized tomography and magnetic resonance imaging which have their own limitations. This study was done to correlate serum Interleukin 6, high sensitivity C reactive protein at the time of admission with neurological worsening assessed by NIHSS at the time of admission and 7 days after admission. 46 Patients admitted in neurology department SAIMS, Indore with first ever ischemic stroke within 72 h of onset were included in the study. All patients with history of stroke of more than 72 h onset, Infection & peripartum stroke were excluded from the study. Disability scoring was done by NIHSS and their serum samples assayed for hsCRP, IL6 by commercially available quantitative sandwich enzyme-linked immunoadsorbent assay kits. Serum samples of 50 control cases which included healthy volunteers and staff from SAIMS were also analyzed for hsCRP, IL6 for comparative study. A significant correlation was observed between NIHSS scoring and serum hsCRP and IL6 at the time of admission. Patients with initial high serum IL6 and hsCRP also showed significant clinical deterioration as assessed by NIHSS scoring 7 days after admission. Elevated hsCRP and IL6 within 72 h of admission strongly correlated with functional disability in study population in India and may serve as useful adjunct to CT Scan in emergency setting.
Similar content being viewed by others
References
Poungvarin N. Stroke in the developing countries. Lancet. 1998;352(SIII):19–22.
Das SK, Banerjee TK, Biswas A, et al. A prospective community based study of stroke in Kolkata, India. Stroke. 2007;38:906.
Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics—a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69–171.
Clark WM. Cytokines and reperfusion injury. Neurology. 1997;49(suppl 4):10–4.
Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenic mediator of ischemic brain damage in rats. Stroke. 1995;26:676–81.
Tanne D, Benderly M, Goldbourt U, Hain M, Tenenbaum A, et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke. 2006;37:1720–4.
Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 2009;40:e380–9.
Castellanos M, Leira R, Tejada J, Gil-Peralta A, Davalos A, et al. Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry. 2005;76:691–5.
Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002;58:624–9.
Dávalos A, Cendra E, Teruel J, Martinez M, Genis D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40:1865–9.
Toni D, Fiorelli M, Gentile M, Bastianello S, Sacchetti ML, Argentino C, et al. Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol. 1995;52:670–5.
Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Effect of blood pressure and diabetes on stroke in progression. Lancet. 1994;344:156–9.
Kwan J, Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM. 2006;99:625–33.
Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis. 1999;19:141–55.
Orion D, Schwammenthal Y, Reshef T, et al. Interleukin-6 and soluble intercellular adhesion molecule-1 in acute brain ischaemia. Eur J Neurol. 2008;15:323–8.
Shenhar-Tsarfaty S, Assayag EB, Bova I, et al. Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res. 2008;122(2):167–73.
Smith CJ, Emsley HCA, Gavin CM, et al. Peak plasma interleukin-6, other peripheral markers of inflammation in the first week of ischemic stroke correlate with brain infarct volume, stroke severity, long-term outcome. BMC Neurol. 2004;4:2.
Ferrarese C, Mascarucci P, Zoia C, et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cerebr Blood Flow Metab. 1999;19:1004–9.
Waje-Andreassen U, Kråkenes J, Ulvestad E, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005;112(4):273–4.
Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PHM, et al. C-reactive protein, carotid intima media thickness and incidence of stroke in elderly: the Cardiovascular Health Study. Circulation. 2003;108:166–70.
Di Napoli M, Papa F, Bacola V. Prognostic influence of increased C Reactive Protein and fibrinogen levels in ischaemic stroke. Stroke. 2001;32:133–8.
Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32:917–24.
Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C Reactive protein measurements after first ischemic stroke. Stroke. 2002;33:2459–64.
Kim JS, Kim YI, Lee KS. Relationship between high-sensitivity C-Reactive Protein and clinical functional outcome after acute ischemic stroke in a Korean Population. Cerebrovasc Dis. 2009;28:545–50.
Panicker JN, Thomas M, Pavithran K, Nair D, Sarma PS. Morbidity predictors in ischaemic stroke. Neurol India. 2003;51:49–51.
Angerio AD, Bialko MF, White BM. C-reactive protein, stroke, statins. Cardiac Emergencies. Crit Care Nurs Q. 2007;30(2):161–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bharosay, A., Saxena, K., Varma, M. et al. Correlation Between Proinflammatory Serum Markers: High Sensitivity C-Reactive Protein, Interleukin-6 with Disability Score in Acute Ischemic Stroke. Ind J Clin Biochem 26, 279–282 (2011). https://doi.org/10.1007/s12291-011-0135-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-011-0135-1